Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Nobel Biocare announces fall in revenue

Nobel Biocare announces fall in revenue

7th November 2008

Nobel Biocare has announced that it has seen a fall in revenue, with growth at constant exchange rates (CER) down one per cent.

The dental solutions company also found that gross profit was also down 3.8 per cent, to 374 million euros (303 million pounds).

Operating cash flow was however up to 103.8 million euros, with the company’s NobelActive also enjoying continued launch success.

Chief executive officer of the company, Domenico Scala, blamed the fall in revenue due to the current economic climate.

He said: “Due to the company?s high operating leverage, the revenue slowdown has adversely affected our margins and led to a disappointing quarterly result.”

“NobelActive customer response continues to be extremely favourable and has already led to more than 100,000 implants being sold,” he added.

The company says that it expects a further slowdown in growth for the remainder of 2008, underperforming the market average for this year.

As well as offering crown, bridge and implant dentistry products, Nobel Biocare provide training, education and clinically documented treatment concepts.

Based in Zurich, Switzerland, the company employs over 2,400 people and has direct sales organisations in 36 countries, with a distribution network spanning over 70 countries.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.